• 

  October 3, 2025

  NIH Launches Nation’s First Dedicated Organoid Development Center

  R.D. Solorzano

• 

  September 29, 2025

  CUTISS Secures CHF 56 Million Series C to Advance Phase 3 Skin-Tissue Therapy

  R.D. Solorzano

• 

  September 23, 2025

  Prellis Biologics and Eli Lilly Sign Multi-Target Antibody Discovery Agreement

  R.D. Solorzano

• 

  September 22, 2025

  Humacyte Reports Positive Data on Bioengineered Vessels for Vascular Repair and Coronary Bypass

  R.D. Solorzano

• 

  September 22, 2025

  eGenesis Wins FDA Green Light for Gene-Edited Pig Kidney Trial

  R.D. Solorzano

• 

  August 25, 2025

  Terumo Acquires OrganOx for $1.5 Billion: A Landmark Deal in Organ Preservation and Transplantation

  R.D. Solorzano

• 

  July 23, 2025

  TISSIUM’s COAPTIUM Connect ushers in photopolymer 3‑D printing for implantables

  R.D. Solorzano

• 

  July 18, 2025

  Xeltis Reports Positive 24-Month Clinical Success for Regenerative CABG Conduit

  R.D. Solorzano

• 

  July 17, 2025

  Aspect Biosystems Showcases Bioprinted Adrenal Tissue Data at ENDO 2025

  R.D. Solorzano

• 

  July 16, 2025

  CollPlant Expands U.S. Footprint with Strategic Hire to Lead Commercial GrowthBusiness of Biofabrication

  R.D. Solorzano